CVS Health Corporation’s stock price plunges to $73.82, marking a 7.21% drop

CVS Health Corporation (CVS)

73.82 USD -5.74 (-7.21%) Volume: 23.67M

CVS Health Corporation’s stock price stands at 73.82 USD, experiencing a significant drop of 7.21% this trading session with a trading volume of 23.67M, reflecting the year-to-date decrease of 6.51%, highlighting the volatility and current market trends.

Latest developments on CVS Health Corporation

CVS Health Corp. (NYSE:CVS) has been in the spotlight recently as investor interest in the company grows, despite underperforming compared to competitors on Monday. Lower Medicare rates have hit health stocks, including CVS, causing a slide in shares. This was further impacted by disappointing final Medicare Advantage rates. Additionally, several financial entities, including Miracle Mile Advisors LLC and AdvisorNet Financial Inc, have reduced their stock holdings in CVS. Despite these challenges, CVS continues to invest in health outcomes, recently dedicating over $3M to initiatives in Phoenix.

CVS Health Corporation on Smartkarma

CVS Health Corp has been receiving positive analyst coverage on Smartkarma, an independent investment research network. According to the research reports by Baptista Research, the company has successfully navigated through a challenging environment and delivered on its financial commitments. This showcases the strength of its diversified business model. Baptista Research also evaluates various factors that could impact the company’s stock price in the near future and conducts an independent valuation using a Discounted Cash Flow methodology. Their report includes a fundamental analysis of the company’s historical financial statements.

In another report by Baptista Research, it is revealed that CVS Health Corporation has exceeded analyst expectations in terms of revenue and earnings. The company’s integrated model has shown significant progress in restoring its Medicare Advantage Star rating. Additionally, its Pharmacy & Consumer Wellness segment has achieved nearly $29 billion in revenues, with the retail pharmacy business performing exceptionally well. This positive coverage by Baptista Research highlights the company’s strong performance and growth potential.

A look at CVS Health Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to the Smartkarma Smart Scores, CVS Health Corp has a positive long-term outlook. The company received a high score of 5 for its dividend, indicating that it is financially stable and has a strong track record of paying dividends to its shareholders. Additionally, CVS Health Corp received a score of 4 for value, suggesting that it is currently undervalued in the market. This makes it an attractive investment option for those looking for potential growth.

While the company scored a 3 for both growth and momentum, it still shows potential for future growth and has a solid foundation for continued success. With its strong presence in the pharmacy and healthcare industry, CVS Health Corp is well-positioned to weather any market fluctuations and remain resilient. Overall, the Smartkarma Smart Scores indicate that CVS Health Corp is a promising company for long-term investment.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma